Stem Cell Factor

Details for Australian Patent Application No. 2003261493 (hide)

Owner Amgen Inc.

Inventors Suggs, Sidney; Bosselman, Robert A; Martin, Francis Hall; Zsebo, Krisztina M

Agent Wrays

Pub. Number AU-B-2003261493

Parent 2002300154

Filing date 7 November 2003

Wipo publication date 27 November 2003

Acceptance publication date 4 January 2007

International Classifications

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C12N 15/19 (2006.01) Mutation or genetic engineering - Interferons

Event Publications

20 November 2003 Complete Application Filed

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003261493

4 January 2007 Application Accepted

  Published as AU-B-2003261493

3 May 2007 Standard Patent Sealed

20 August 2009 Assignment Registered

  Amgen Inc. The patent has been assigned to Biovitrum AB (publ)

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003261494-Computer security device

2003261492-Vaccine